期刊文献+

非酒精性脂肪性肝病的药物治疗进展 被引量:3

下载PDF
导出
摘要 非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)是目前最常见的肝脏疾病之一。临床应对此病进行药物及综合治疗,以期减缓或减少肝硬化等终末期肝病的发生,降低患者肝脏相关疾病病死率。到目前为止,约有4类药物对NAFLD患者具有一定的临床效果,
作者 陈林艳 李海
出处 《中国肝脏病杂志(电子版)》 CAS 2012年第2期60-64,共5页 Chinese Journal of Liver Diseases:Electronic Version
  • 相关文献

参考文献35

  • 1Angulo P,Lindor KD. Treatment of non-alcoholic steatohepatitis[J].Best Practice and Research in Clinical Gastroenterology,2002.797-810.
  • 2楼时先,陆小文,包慧兰,郑伟英.2型糖尿病脂肪肝与胰岛素抵抗的关系探讨[J].中国医师进修杂志,2011,34(15):66-68. 被引量:5
  • 3Marchesini G,Brizi M,Bianchi G. Metformin in non-alcoholic steatohepatitis[J].The Lancet,2001,(9285):893-894.doi:10.1016/S0140-6736(01)06042-1.
  • 4Nair S,Diehl AM,Wiseman M. Metformin in the treatment of non-alcoholic steatohepatitis:a pilot open label trial[J].Alimentary Pharmacology and Therapeutics,2004.23-28.doi:10.1111/j.1365-2036.2004.02025.x.
  • 5Lavine JE,Schwimmer JB,Van Natta ML. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents:the TONIC randomized controlled trial[J].Journal of the American Medical Association,2011.1659-1668.
  • 6Uygun A,Kadayifci A,Isik AT. Metformin in the treatment of patients with non-alcoholic steatohepatitis[J].Alimentary Pharmacology and Therapeutics,2004.537-544.doi:10.1111/j.1365-2036.2004.01888.x.
  • 7Neuschwander-Tetri BA,Brunt EM,Wehmeier KR. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone[J].Hepatology,2003.1008-1017.
  • 8Ratziu V,Giral P,Jacqueminet S. Rosiglitazone for nonalcoholic steatohepatitis:one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial[J].Gastroenterology,2008.100-110.
  • 9Ratziu V,Charlotte F,Bernhardt C. Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis:results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial[J].Hepatology,2010.445-453.
  • 10Torres DM,Jones FJ,Shaw JC. Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans:A 12-month randomized,prospective,open-label trial[J].Hepatology,2011.1631-1639.

二级参考文献73

共引文献60

同被引文献26

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部